ImmunoPrecise Antibodies (IPA) News Today C$6.50 +0.05 (+0.78%) (As of 11/25/2022) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period $20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer TherapiesNovember 13, 2024 | finance.yahoo.comImmunoPrecise Antibodies to Join AI Drug SummitOctober 21, 2024 | markets.businessinsider.comImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein DesignOctober 10, 2024 | finance.yahoo.comImmunoPrecise Subsidiary Signs Material Transfer Agreement with BiotheusOctober 2, 2024 | finance.yahoo.comMaintained Buy Rating for ImmunoPrecise Antibodies on Strong Revenue and Strategic Growth ProspectsSeptember 18, 2024 | markets.businessinsider.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2025 Earnings Call TranscriptSeptember 18, 2024 | msn.comImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call TranscriptSeptember 16, 2024 | seekingalpha.comOptions Volatility and Implied Earnings Moves Today, September 16, 2024September 16, 2024 | msn.comImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025September 16, 2024 | finance.yahoo.comEarnings To Watch: ImmunoPrecise Antibodies Ltd (IPA) Reports Q1 2025 ResultSeptember 13, 2024 | finance.yahoo.comBuy Rating Affirmed: ImmunoPrecise’s Strong Financials and AI Advancements Signal Growth PotentialJuly 31, 2024 | markets.businessinsider.comIPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*March 14, 2024 | finance.yahoo.comImmunoPrecise Antibodies Ltd.: ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14December 7, 2023 | finanznachrichten.deBioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database ResearchNovember 13, 2023 | benzinga.comEXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence RetrievalNovember 13, 2023 | msn.comIPA Provides Update on Growth Strategy and Recent Share Price MovementOctober 23, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (IPA) Could Find a Support Soon, Here's Why You Should Buy the Stock NowOctober 11, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (TQB.F)August 26, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2023 Earnings Call TranscriptJuly 13, 2023 | finance.yahoo.comBenchmark Reiterates ImmunoPrecise Antibodies (IPA) Speculative Buy RecommendationJuly 12, 2023 | msn.comImmunoPrecise Antibodies Stock (NASDAQ:IPA), Guidance and ForecastMay 17, 2023 | benzinga.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2023 Earnings Call TranscriptMarch 21, 2023 | hk.finance.yahoo.comImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue EstimatesMarch 16, 2023 | finance.yahoo.comEarnings Outlook For ImmunoPrecise AntibodiesMarch 15, 2023 | msn.comHere's Why We're Watching ImmunoPrecise Antibodies' (CVE:IPA) Cash Burn SituationSeptember 16, 2022 | finance.yahoo.comNIAID Confirms IPA's PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75September 16, 2022 | stockhouse.comImmunoPrecise Antibodies Ltd. (IPA) Q1 2023 Earnings Call TranscriptSeptember 16, 2022 | seekingalpha.comNIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75September 14, 2022 | nz.finance.yahoo.comLive Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope's Efficacy Against SARS-CoV-2 Variants Including BA.5August 30, 2022 | stockhouse.comImmunoPrecise antibody cocktail shows neutralizing activity versus Omicron BA.2 in lab testApril 20, 2022 | seekingalpha.comImmunoPrecise Antibodies reports Q3 resultsMarch 17, 2022 | seekingalpha.comImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope® TATX-03 Antibody Cocktail Manufacturing CollaborationDecember 20, 2021 | yahoo.comImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development ProgramNovember 30, 2021 | finance.yahoo.comImmunoPrecise Announces Participation at the H.C. Wainwright 23nd Annual Global Investment Conference on September 13-15, 2021 (Virtual Conference)September 7, 2021 | stockhouse.comUnusual Options Activity Insight: ImmunoPrecise AntibodiesAugust 4, 2021 | benzinga.comImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2021July 28, 2021 | stockhouse.comImmunoPrecise's PolyTope(TM) TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus AssaysJuly 23, 2021 | stockhouse.comImmunoPrecise’s TATX-03 Antibody Cocktail Potently Neutralizes Delta VariantJuly 23, 2021 | nasdaq.comImmunoPrecise’s PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus AssaysJuly 22, 2021 | apnews.comImmunoPrecise SkyRockets On Delta Variant Therapy News: What's Next?July 22, 2021 | benzinga.comWhy ImmunoPrecise Antibodies Stock Is Soaring TodayJuly 22, 2021 | benzinga.com Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Man behind OpenAI makes shocking new bet (Ad)Billionaire Sam Altman has become one of the most powerful men in the world by running OpenAI… But there’s a far lesser known investment he’s making that could put OpenAI to shame. In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI… And the US Military… not to mention hundreds of other giant companies around the globe. To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office… Which ordered the government to take this incredible new technology seriously. Check out our report right here. IPA Media Mentions By Week IPA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPA News Sentiment▼0.000.47▲Average Medical News Sentiment IPA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPA Articles This Week▼00▲IPA Articles Average Week Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aimia News Today Fennec Pharmaceuticals News Today Andean Precious Metals News Today Cardiol Therapeutics News Today Gear Energy News Today International Tower Hill Mines News Today Medicenna Therapeutics News Today Graphite One News Today EQ News Today Moneta Gold News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:IPA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPA Stock Alerts